PCGF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.174800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.775970E-01
Normal-vs-Stage2
3.351800E-01
Normal-vs-Stage3
7.631900E-02
Normal-vs-Stage4
4.504600E-01
Stage1-vs-Stage2
8.715800E-01
Stage1-vs-Stage3
3.387200E-01
Stage1-vs-Stage4
9.905600E-01
Stage2-vs-Stage3
3.659600E-01
Stage2-vs-Stage4
8.852200E-01
Stage3-vs-Stage4
5.929400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.139200E-01
Normal-vs-AfricanAmerican
4.371000E-01
Normal-vs-Asian
3.478400E-01
Caucasian-vs-AfricanAmerican
6.918200E-01
Caucasian-vs-Asian
8.661000E-01
AfricanAmerican-vs-Asian
6.683200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.497800E-01
Normal-vs-Female
4.396600E-01
Male-vs-Female
6.521800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.830500E-02
Normal-vs-Age(41-60Yrs)
5.399800E-01
Normal-vs-Age(61-80Yrs)
2.522600E-01
Normal-vs-Age(81-100Yrs)
2.460800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.393400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.428400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.701400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.058300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.935000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.412600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.231200E-01
Normal-vs-Daily Drinker
1.899950E-01
Normal-vs-Weekly Drinker
8.266600E-01
Normal-vs-Occasional Drinker
1.733350E-01
Normal-vs-Social Drinker
3.709000E-01
Non Drinker-vs-Daily Drinker
5.205000E-01
Non Drinker-vs-Weekly Drinker
1.581580E-01
Non Drinker-vs-Occasional Drinker
9.472200E-01
Non Drinker-vs-Social Drinker
6.887200E-01
Daily Drinker-vs-Weekly Drinker
1.001640E-01
Daily Drinker-vs-Occasional Drinker
5.971400E-01
Daily Drinker-vs-Social Drinker
3.924800E-01
Weekly Drinker-vs-Occasional Drinker
1.849380E-01
Weekly Drinker-vs-Social Drinker
3.930000E-01
Occasional Drinker-vs-Social Drinker
6.619200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.310600E-01
Normal-vs-Grade 2
9.021800E-01
Normal-vs-Grade 3
9.061800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.086800E-01
Grade 1-vs-Grade 3
1.109240E-01
Grade 1-vs-Grade 4
8.310600E-01
Grade 2-vs-Grade 3
9.131600E-01
Grade 2-vs-Grade 4
9.021800E-01
Grade 3-vs-Grade 4
9.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.656600E-01
Normal-vs-NonDiabetic
2.719200E-01
Diabetic-vs-NonDiabetic
9.097600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.631200E-01
Normal-vs-NoPancreatitis
2.924800E-01
Pancreatitis-vs-NoPancreatitis
9.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.987400E-01
Normal-vs-N1
3.327400E-01
N0-vs-N1
8.010800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.708200E-01
Normal-vs-TP53-NonMutant
5.306400E-01
TP53-Mutant-vs-TP53-NonMutant
6.065600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
